TABLE 2.

Association between polycystic ovary syndrome types and venous thromboembolism stratified by age groups

PCOS types	Age groups
	18–24 y	25–34 y	35–45 y
aOR (95% CI)a
No PCOSb	Reference	Reference	Reference
Any PCOSc	3.26 (2.61–4.08)	2.39 (2.12–2.70)	2.05 (1.84–2.28)
Phenotype Ad	3.05 (2.29–4.07)	2.25 (1.91–2.65)	1.98 (1.75–2.25)
Phenotype Be	5.23 (2.88–9.51)	2.25 (1.35–3.74)	1.87 (1.11–3.18)
Phenotype Cf	2.87 (1.80–4.58)	2.35 (1.91–2.89)	2.18 (1.73–2.73)
Phenotype Dg	3.11 (1.29–7.49)	3.06 (2.06–4.54)	2.37 (1.49–3.78)

aOR, adjusted odds ratio; CI, confidence interval; PCOS, polycystic ovary syndrome.

^aMultivariate logistic regression model was adjusted for pregnancy, oral contraceptive pill use, region, diabetes, and obesity;

^bWomen without any PCOS phenotype;

^cWomen with any PCOS phenotype;

^dWomen with clinical hyperandrogenism and menstrual or ovulatory dysfunction, or both;

^eWomen with hyperandrogenism and polycystic ovaries;

^fWomen with menstrual or ovulatory dysfunction, or both, and polycystic ovaries;

^gWomen with clinical hyperandrogenism; menstrual or ovulatory dysfunction, or both; and polycystic ovaries.

Okoroh. Polycystic ovary syndrome and venous thromboembolism. Am J Obstet Gynecol 2012.